Does Rallies show Form 4 insider transactions for EHC?

Yes. Rallies tracks EHC insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is EHC research on Rallies investment advice?

No. Rallies provides research, data, and educational context for EHC. It does not provide personalized investment advice.

EHC (Encompass Health Corporation Common Stock) Stock Analysis - Insider Trades

Encompass Health Corporation Common Stock (EHC) is a publicly traded Healthcare sector company. As of May 21, 2026, EHC trades at $105.99 with a market cap of $10.53B and a P/E ratio of 17.35. EHC moved +1.20% today. Year to date, EHC is -1.61%; over the trailing twelve months it is -12.93%. Its 52-week range spans $87.85 to $127.99. Analyst consensus is strong buy with an average price target of $141.25. Rallies surfaces EHC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading EHC stock inside the company?

Recent EHC insider activity includes COLTHARP DOUGLAS E sold 27.69K, COLTHARP DOUGLAS E sold 1, Tuer Patrick William sold 682, Fay Edmund sold 11.94K, and Tarr Mark J sold 16.22K. Rallies tracks insider transaction dates, shares, prices, and estimated values.

EHC Key Metrics

Key financial metrics for EHC
Metric	Value
Price	$105.99
Market Cap	$10.53B
P/E Ratio	17.35
EPS	$6.08
Dividend Yield	0.19%
52-Week High	$127.99
52-Week Low	$87.85
Volume	0
Avg Volume	0
Revenue (TTM)	$6.07B
Net Income	$810.80M
Gross Margin	0.00%

Recent EHC Insider Trades

COLTHARP DOUGLAS E sold 27.69K (~$2.96M) on May 15, 2026.
COLTHARP DOUGLAS E sold 1 (~$107.28) on May 15, 2026.
Tuer Patrick William sold 682 (~$71.31K) on May 11, 2026.
Fay Edmund sold 11.94K (~$1.28M) on Mar 9, 2026.
Tarr Mark J sold 16.22K (~$1.75M) on Feb 11, 2026.

Latest EHC News

Encompass Health Prices $500M of 5.875% Senior Notes Due 2034 — May 14, 2026
Encompass Health to Open 50-Bed Rehab Hospital in Idaho by 2028 — May 11, 2026
Encompass Health Opens 50-Bed, 66,000-Square-Foot Rehab Hospital in Concordville, PA — May 5, 2026
Encompass Health drops 3% as post-earnings rally fades amid fund-selling filing — May 5, 2026
Encompass Health jumps as Q1 results top expectations and 2026 guidance rises — May 1, 2026

EHC Analyst Consensus

6 analysts cover EHC: 0 strong buy, 6 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $141.25.

Common questions about EHC

Who is trading EHC stock inside the company?: Recent EHC insider activity includes COLTHARP DOUGLAS E sold 27.69K, COLTHARP DOUGLAS E sold 1, Tuer Patrick William sold 682, Fay Edmund sold 11.94K, and Tarr Mark J sold 16.22K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for EHC?: Yes. Rallies tracks EHC insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is EHC research on Rallies investment advice?: No. Rallies provides research, data, and educational context for EHC. It does not provide personalized investment advice.